Detalhe da pesquisa
1.
SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway.
Bioorg Med Chem Lett
; 29(16): 2307-2315, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253529
2.
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy.
J Med Chem
; 65(19): 12895-12924, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127295